Andrew A Nierenberg Selected Research

Fluoxetine (Prozac)

6/2012	Prevalence of MTHFR C677T and MS A2756G polymorphisms in major depressive disorder, and their impact on response to fluoxetine treatment.
7/2011	Response rates to fluoxetine in subjects who initially show no improvement.
2/2011	Residual symptoms after remission of major depressive disorder with fluoxetine and risk of relapse.
1/2009	The response of psychotic-like symptoms to fluoxetine monotherapy in non-psychotic major depressive disorder.
9/2006	Predictors of relapse in a prospective study of fluoxetine treatment of major depression.
7/2006	Somatic symptoms in outpatients with major depressive disorder treated with fluoxetine.
12/2005	The relationship between serum folate, vitamin B12, and homocysteine levels in major depressive disorder and the timing of improvement with fluoxetine.
10/2005	A Double-blind, randomized trial of St John's wort, fluoxetine, and placebo in major depressive disorder.
6/2005	Hypericum extract in patients with MDD and reversed vegetative signs: re-analysis from data of a double-blind, randomized trial of hypericum extract, fluoxetine, and placebo.
3/2005	Obesity among outpatients with major depressive disorder.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrew A Nierenberg Research Topics

Disease

79	Major Depressive Disorder (Major Depressive Disorders) 01/2021 - 03/2002
74	Bipolar Disorder (Manic Depressive Psychosis) 02/2022 - 06/2003
16	Treatment-Resistant Depressive Disorder 08/2010 - 03/2002
10	Mania (Manias) 01/2021 - 04/2007
8	Mood Disorders (Mood Disorder) 01/2021 - 02/2004
6	Anxiety Disorders (Anxiety Disorder) 10/2019 - 07/2003
6	Substance-Related Disorders (Drug Abuse) 01/2018 - 10/2004
5	Sleep Initiation and Maintenance Disorders (Insomnia) 08/2014 - 01/2002
4	Mental Disorders (Mental Disorder) 01/2022 - 05/2002
4	Inflammation (Inflammations) 01/2022 - 01/2018
4	Depressive Disorder (Melancholia) 01/2021 - 04/2002
4	Medically Unexplained Symptoms 07/2006 - 05/2003
3	Tardive Dyskinesia 01/2021 - 01/2019
3	Weight Gain 01/2020 - 01/2002
3	Alcoholism (Alcohol Abuse) 01/2020 - 03/2010
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2022 - 11/2020
2	Body Weight (Weight, Body) 01/2020 - 03/2005
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2019 - 10/2004
2	Psychotic Disorders (Schizoaffective Disorder) 01/2018 - 08/2012
2	Personality Disorders (Personality Disorder) 11/2003 - 09/2002
2	Hypercholesterolemia 05/2003 - 01/2003
2	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 05/2002 - 05/2002
2	Dysthymic Disorder 04/2002 - 01/2002
1	Osteoporosis 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Movement Disorders (Movement Disorder) 12/2020
1	Clostridium Infections 11/2020
1	Bulimia (Binge Eating) 01/2020
1	Wounds and Injuries (Trauma) 01/2019
1	Flushing 03/2018
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2018
1	Huntington Disease (Huntington's Disease) 01/2018
1	Parkinson Disease (Parkinson's Disease) 01/2018

Drug/Important Bio-Agent (IBA)

50	Antidepressive Agents (Antidepressants)IBA 01/2021 - 09/2002
32	LithiumIBA 02/2022 - 02/2003
23	Fluoxetine (Prozac)FDA LinkGeneric 06/2012 - 01/2002
16	Antipsychotic Agents (Antipsychotics)IBA 02/2022 - 02/2004
16	Quetiapine Fumarate (Seroquel)FDA Link 01/2022 - 02/2014
14	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 03/2015 - 01/2002
11	Citalopram FDA LinkGeneric 05/2009 - 01/2006
7	Pharmaceutical PreparationsIBA 01/2020 - 03/2010
7	Folic Acid (Vitamin M)FDA LinkGeneric 11/2013 - 03/2002
7	Nortriptyline (Aventyl)FDA LinkGeneric 07/2006 - 01/2003
5	CholesterolIBA 01/2021 - 01/2003
5	HomocysteineIBA 11/2013 - 08/2004
5	Mirtazapine (Rexer)FDA LinkGeneric 08/2010 - 01/2002
5	Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric 08/2010 - 12/2004
5	Bupropion (Wellbutrin)FDA LinkGeneric 01/2009 - 09/2002
5	Sertraline (Zoloft)FDA LinkGeneric 01/2009 - 07/2002
4	Valproic Acid (Depakote)FDA LinkGeneric 01/2022 - 04/2006
4	Lamotrigine (Lamictal)FDA LinkGeneric 01/2022 - 02/2006
4	Biological ProductsIBA 01/2022 - 09/2006
4	Buspirone (Buspar)FDA LinkGeneric 12/2012 - 03/2006
4	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 12/2005 - 08/2004
3	Anticonvulsants (Antiepileptic Drugs)IBA 02/2022 - 05/2006
3	Triglycerides (Triacylglycerol)IBA 02/2022 - 03/2015
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2018
3	Biomarkers (Surrogate Marker)IBA 01/2018 - 04/2011
3	BenzodiazepinesIBA 02/2015 - 02/2010
3	3,4-methylenedioxyethamphetamine (MDEA)IBA 09/2014 - 01/2002
3	Inositol (Myoinositol)IBA 01/2013 - 02/2006
3	Triiodothyronine (Liothyronine)FDA LinkGeneric 06/2008 - 08/2005
2	AcidsIBA 01/2022 - 12/2008
2	LipidsIBA 01/2021 - 06/2014
2	Eicosapentaenoic AcidIBA 01/2021 - 01/2015
2	Topiramate (Topamax)FDA LinkGeneric 01/2020 - 03/2016
2	Anti-Anxiety Agents (Anxiolytics)IBA 01/2019 - 10/2004
2	Docosahexaenoic AcidsIBA 01/2015 - 09/2008
2	MelatoninIBA 12/2012 - 01/2009
2	Escitalopram FDA Link 10/2011 - 02/2007
2	Paroxetine (Paxil)FDA LinkGeneric 08/2010 - 01/2002
1	Glucose (Dextrose)FDA LinkGeneric 02/2022
1	C-Reactive ProteinIBA 01/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021
1	Dopamine (Intropin)FDA LinkGeneric 01/2021
1	Carbamazepine (Tegretol)FDA LinkGeneric 12/2020
1	vasectrin II (VS II)IBA 10/2019
1	valbenazineIBA 01/2019
1	AntioxidantsIBA 01/2018
1	Glutathione (Reduced Glutathione)IBA 01/2018
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2018
1	Minocycline (Cyclops)FDA LinkGeneric 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	Illicit Drugs (Recreational Drugs)IBA 01/2018
1	17-hydroxyestrane-3-carbonitrile (ECN)IBA 01/2018
1	peroxisome-proliferator-activated receptor-gamma coactivator-1IBA 01/2018
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2018
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2018

Therapy/Procedure

18	Drug Therapy (Chemotherapy) 10/2019 - 07/2002
14	Therapeutics 09/2016 - 09/2004
2	Transcranial Magnetic Stimulation 10/2019 - 01/2019
2	Cognitive Training 06/2014 - 10/2010
2	Secondary Prevention 08/2010 - 06/2003
2	Vagus Nerve Stimulation 09/2008 - 09/2005
1	Fecal Microbiota Transplantation 11/2020
1	Ambulatory Care (Outpatient Care) 01/2020
1	Polypharmacy 10/2019
1	Aftercare (After-Treatment) 01/2019
1	Bathroom Equipment 03/2018